Population
Individuals with Parkinson disease or isolated neurogenic orthostatic hypotension
Design
Review
Key result
Accurate identification and individualized treatment of neurogenic orthostatic hypotension in Parkinson disease may reduce the risk of falls, cognitive impairment, and death.
Authors
Loading...
Supports screening in Parkinson disease; leaves open need for prospective trials to confirm benefit.
Accurate identification and individualized treatment of neurogenic orthostatic hypotension in Parkinson disease is crucial and may reduce the risk of falls, cognitive impairment, and death.
Lamotte et al. (2022) conducted a review in Orthostatic hypotension in Parkinson disease. Accurate identification and individualized treatment of neurogenic orthostatic hypotension in Parkinson disease may reduce the risk of falls, cognitive impairment, and death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: